Appointment of Managing Director
-
Appointed Kim Byung-rok (born 1967) as Managing Director
-
Purpose: Ensure management stability amid change of control
-
Term: May 15, 2026 ~ May 14, 2027
-
Scope: Overall internal and external management operations
-
Approved by board with 2 outside directors present
KOSDAQ Filing Information
-
Filing: Major Management Matters Related to Investment Decision (Appointment of Managing Director)
-
Company: CHA Vaccine Research Institute (261780)
-
Submission: CHA Vaccine Research Institute
-
Receipt: 05-15-2026
-
Under KRX KOSDAQ Market Division